Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • M_staats
    Junior Member
    • Mar 2013
    • 1

    #1

    Discrepancy between HTSeq-count counts and total mapped reads

    Hi All,

    There seems to be a rather large discrepancy between the number of mapped Illumina reads and the total number of HTSeq counts (gene counts + counts with no_feature + ambiguous counts + too_low_aQual + not_aligned + alignment_not_unique).

    For instance:
    I used Tophat2 to map paired-end illumina reads. My two FASTQ files contain a total of 39785174 reads of which 4177881 were unmapped (unmapped.bam). A total of 35607293 reads were mapped (accepted_hits.bam), of which 31390707 were uniquely mapped (grep -w "NH:i:1" accepted_hits.sam | sort | uniq | wc -l).

    My input HTSeq-count command was:
    htseq-count --mode=union --stranded=no --type=exon --idattr=gene_id accepted_hits.nsorted.sam Solanum_tuberosum.3.0.17.gtf > HTSeq_counts_UNION_ENSEMBL_GTF.out

    The HTSeq output is:
    Total sum of gene counts 13319749
    no_feature 3150201
    ambiguous 346347
    too_low_aQual 0
    not_aligned 0
    alignment_not_unique 9024735

    The sum of HTSeq-count is 25841032 counts. Shouldn't the sum of counts be equal to the total number of mapped reads (35607293)? Please help me explain this discrepancy.

    Thanks in advance for the answer!
    Best,
    Last edited by M_staats; 03-21-2013, 05:16 AM.
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    htseq-count counts read pairs, not reads. Maybe this explains it.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...